Use this URL to cite or link to this record in EThOS: http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.553707
Title: The immunogenicity of mycobacterial shock proteins and their potential as novel vaccines to mycobacterial infection
Author: Corbett, Clare
Awarding Body: University of Surrey
Current Institution: University of Surrey
Date of Award: 2012
Availability of Full Text:
Access from EThOS:
Abstract:
Tuberculosis causes the deaths of 1.8 million people per year and imposes a significant health burden on infected people. Tuberculosis presents many challenges in terms of both treatment and infection prevention. The chemotherapy course lasts for 6 months and there are increasing numbers of drug-resistant infections. The current BCG vaccination fails to control adult pulmonary disease and can cause infections in susceptible individuals. To address the deficiencies in protection induced by BCG vaccination research has been directed towards enhancement or replacement vaccine strategies. Mycobacterial Hsp70 has been shown to chaperone peptides in vivo and in vitro and has immunostimulatory activity, promoting maturation of antigen-presenting cells and the release of proinfiammatory cytokines. This project has sought to harness the immunostimulatory activity and the peptide binding capacity of Hsp70 to deliver a range of mycobacterial peptides to the host immune system as a novel vaccine to mycobacteria. This study showed that mycobacterial Hsp70 can be purified from BCG in complex with a range of different peptides and vaccination with the Hsp70-peptide complexes induced activation and IFNy production by CD4+ T-cells in addition to the secretion of IL-2, IFNy and lNFa. Conversely, vaccination with Hsp70 alone did not induce significant T-cell activation or cytokine production. Overexpression of Hsp70 in BCG did not enhance mycobacterial antigen-specific T-cell activation or cytokine production compared to vaccination with the BCG parent strain. Overexpression of both Hsp70 and GroEL in BCG did not induce a mycobacterial antigen-specific T -cell response. Recombinant Mycobacterium vaccae were engineered to express M tuberculosis alpha- crystallin 2 (Acr2) and the fusion protein construct Hsp70-Acr2. Vaccination with M vaccae that overexpressed Acr2 resulted in Acr2-specific IFNy production by CD4+ T -cells. M.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.553707  DOI: Not available
Share: